- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/10 - AntiepilepticsAnticonvulsants for petit-mal
Patent holdings for IPC class A61P 25/10
Total number of patents in this class: 38
10-year publication summary
|
2
|
0
|
3
|
5
|
1
|
2
|
5
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 236 |
5 |
| Jazz Pharmaceuticals Research UK Limited | 176 |
3 |
| Pfizer Inc. | 3367 |
2 |
| Centre National de La Recherche Scientifique | 10321 |
2 |
| GW Pharma Limited | 84 |
2 |
| Umecrine AB | 6 |
2 |
| The University of North Carolina at Chapel Hill | 2025 |
2 |
| F. Hoffmann-La Roche AG | 7926 |
1 |
| Hoffmann-La Roche Inc. | 3379 |
1 |
| The Regents of the University of California | 19812 |
1 |
| Abbvie Inc. | 1802 |
1 |
| Takeda Pharmaceutical Company Limited | 2704 |
1 |
| Aphp (assistance Publique-hopitaux de Paris) | 64 |
1 |
| Astellas Pharma Inc. | 1086 |
1 |
| Daiichi Sankyo Company, Limited | 1852 |
1 |
| Ecole Pratique des Hautes Etudes | 36 |
1 |
| ICM - Institut du Cerveau et de La Moelle Epiniere | 57 |
1 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3360 |
1 |
| Katholieke Universiteit Leuven | 1174 |
1 |
| Sage Therapeutics, Inc. | 362 |
1 |
| Other owners | 7 |